Clinical Trial Update: European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 proof-of-concept trial in relapsed or refractory pediatric tumors, evaluating therapeutic stratification by molecular abnormalities; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Pediatric Cancer | Phase 1, Phase 2 | Status: RECRUITING